Navigation Links
Genrate: a generative model that finds and scores new genes and exons in genomic microarray data

Abstract : Recently, researchers have made some progress in using microarrays to validate predicted exons in genome sequence and find new gene structures. However, current methods rely on separately making threshold-based decisions on intensity of expression, similarity of expression profiles, and arrangements of exons in the genome.

We have taken a Bayesian approach and developed GenRate, a generative model that accounts for both genome-wide expression data taken from multiple conditions (e.g. tissues) and co-location and density of probes in DNA sequence data.

GenRate balances probabilistic evidence derived from different sources and outputs scores (log-likelihoods) for each gene model, enabling the estimation of false-positive and false-negative rates. The model has a number of local minima that is exponential in the length of the DNA sequence data, so direct application of the EM learning algorithm produces poor results. We describe a novel way of parameterizing the model using examples from the data set, so that good solutions are found using an efficient algorithm. We apply GenRate to a subset of mouse genome-wide expression data that we have created, and discuss the statistical significance of the genes found by GenRate. Three of the highest-ranking gene structures found by GenRate, each containing thousands of bases from the genome, are confirmed using RT-PCR experiments.


'"/>

Source:PubMed


Page: 1

Related biology news :

1. Pinpointing the cause of a neurodegenerative disorder
2. Study ties new cell-death mechanism to developmental and degenerative brain disorders
3. Sticky mice lead to discovery of new cause of neurodegenerative disease
4. Nanotechnology propels advances in regenerative medicine research
5. Moonlighting enzyme linked to neurodegenerative disease
6. Stanford scientists make major breakthrough in regenerative medicine
7. Stem cells act through multiple mechanisms to benefit mice with neurodegenerative disease
8. Scientists identify new model Of NK cell development
9. Molecular models advance the fight against malaria
10. NYU and MSKCC research provides model for understanding chemically induced cancer initiation
11. Genetic therapy reverses nervous system damage in animal model of inherited human disease
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/2/2017)... -- Who risk to be deprived of its imprint ... https://www.reportbuyer.com/product/4313699/ WILL APPLE AND SAMSUNG CONFRONT ... sensors using capacitive technology represent a fast growing market, ... an increase of 360% of the number of fingerprint ... sensor market between 2014 and 2017 (source : N+1 ...
(Date:3/1/2017)... Mass. , March 1, 2017  Aware, Inc. ... services, announced that Richard P. Moberg has ... and co-President and Chief Financial Officer and Treasurer of ... continue to serve as a member of the Board ... Russell , Aware,s co-Chief Executive Officer and co-President, General ...
(Date:2/28/2017)... 2017 News solutions for biometrics, bag drop ... ... 14 to 16 March, Materna will present its complete end-to-end ... travel is a real benefit for passengers. To accelerate the ... passenger touch point solutions to take passengers through the complete ...
Breaking Biology News(10 mins):
(Date:3/22/2017)... MONICA, Calif. , March 22, 2017 /PRNewswire/ ... are proud to announce their extended partnership and ... will be headlined by the 21 st ... BIOMEDevice Boston, taking place May 3-4, 2017. ... Advanced Medical Technology Association (ADVAMED) President and CEO, ...
(Date:3/22/2017)... 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... ), a clinical-stage pharmaceutical company focused ... announced today that Dr. Miriam Kidron , ... titled, "Oral Insulin for Diabetes Treatment: Bypassing the ... and Peptide Therapeutics (OPT) Boston Conference in ...
(Date:3/22/2017)... ALBANY, New York , March 22, 2017 /PRNewswire/ ... market is largely fragmented, states a research report by ... Sanofi S.A., Pfizer Inc., Amgen Inc., and AbbVie Inc., ... market in 2015. The prominent players in this market ... to expand their product portfolio, which is likely to ...
(Date:3/22/2017)... , March 22, 2017 /PRNewswire/ - FACIT ... (the "Company" or "Propellon"), a start-up created by ... anti-cancer therapeutics. FACIT,s investment, combined with non-dilutive capital, ... program. The seed funding enables Propellon to accelerate ... the Company for financing and/or entering a strategic ...
Breaking Biology Technology: